News & Analysis as of

Pharmaceutical Industry › Life Sciences › Russia

Jones Day

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 120

Jones Day on

This regular alert covers key policy and regulatory developments related to EU geopolitical risks, including in particular, economic security, Russia’s war against Ukraine, health threats, and cyber threats. It does not...more

McDonnell Boehnen Hulbert & Berghoff LLP

Life Sciences Business Leaders Call for Immediate and Complete Economic Disengagement from Russia

McDonnell Boehnen Hulbert & Berghoff LLP on

In an open letter posted on February 26, six life sciences business leaders called on other members of their industry "to cease all business involvement in Russia."  The authors of the open letter included Meg Alexander,...more

McDonnell Boehnen Hulbert & Berghoff LLP

News from Abroad: Eurasian Patent Office Launches Its Pharmaceutical Register

McDonnell Boehnen Hulbert & Berghoff LLP on

On March 1, 2021, the Eurasian Patent Office (EAPO) launched the EAPO Pharmaceutical Register (the 'Register').  The Register lists Eurasian patents that relate to the active pharmaceutical ingredients of the drugs according...more

Hogan Lovells

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells on

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. ...more

Robinson+Cole Data Privacy + Security Insider

Chinese and Russian Hackers Targeting COVID-19 Vaccine Makers in U.S. Crosshairs

Robinson+Cole Data Privacy + Security Insider on

Last week, authorities from the United States, United Kingdom and Canada accused a well-known hacker group tied to the Russian government, APT29 a/k/a Cozy Bear of using malware to exploit security vulnerabilities to enable...more

Morgan Lewis

Mandatory Ceiling Price Adjustment for Essential Drugs in Russia

Morgan Lewis on

Last month, the Russian government passed a decree (the Decree) amending the rules on state regulation of ceiling prices for drugs included in the Vital and Essential Drugs List (Essential Drugs), which is approved annually....more

Hogan Lovells

Online sale of pharmaceuticals in Russia remains prohibited and lawmakers are yet to pass the bill allowing online sales

Hogan Lovells on

Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical licence....more

Hogan Lovells

Hogan Lovells Moscow Life Sciences team secures major win in a precedent patent case for Novartis against a generic producer in...

Hogan Lovells on

Led by partner Natalia Gulyaeva, the Hogan Lovells Moscow team represented Novartis in a precedent case for pharma business proving that one can obtain an injunction using patent rights against a generic in Russia before the...more

Hogan Lovells

A road map to Life Sciences M&A in Russia

Hogan Lovells on

U.S.-based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions. In this series, members of our European Life Sciences Transactions...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide